Privia Health Group, Inc. (NASDAQ:PRVA) Stock Position Lifted by Victory Capital Management Inc.

Victory Capital Management Inc. lifted its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 62.0% during the fourth quarter, Holdings Channel reports. The institutional investor owned 290,009 shares of the company’s stock after buying an additional 110,960 shares during the quarter. Victory Capital Management Inc.’s holdings in Privia Health Group were worth $5,670,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. GSA Capital Partners LLP lifted its position in shares of Privia Health Group by 228.1% in the 3rd quarter. GSA Capital Partners LLP now owns 50,975 shares of the company’s stock valued at $928,000 after acquiring an additional 35,439 shares in the last quarter. MQS Management LLC bought a new position in shares of Privia Health Group during the 3rd quarter valued at $217,000. KBC Group NV lifted its position in shares of Privia Health Group by 34.6% in the third quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after buying an additional 871 shares during the last quarter. Intech Investment Management LLC bought a new position in shares of Privia Health Group in the third quarter valued at approximately $462,000. Finally, Charles Schwab Investment Management Inc. lifted its position in Privia Health Group by 6.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,064,224 shares of the company’s stock worth $19,380,000 after acquiring an additional 65,152 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Performance

Shares of Privia Health Group stock opened at $23.75 on Friday. The firm has a market cap of $2.86 billion, a P/E ratio of 237.52, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $26.04. The firm’s 50-day simple moving average is $23.36 and its 200-day simple moving average is $20.91.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on PRVA shares. Macquarie assumed coverage on Privia Health Group in a research report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target on the stock. JMP Securities set a $29.00 price target on Privia Health Group in a research report on Friday, February 28th. JPMorgan Chase & Co. upped their price target on Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Friday, November 29th. Needham & Company LLC raised their price objective on shares of Privia Health Group from $25.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, February 28th. Finally, Piper Sandler upped their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a research note on Friday, February 28th. One research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, Privia Health Group currently has a consensus rating of “Buy” and an average target price of $26.67.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.